http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PT-100855-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
filingDate 1992-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bc148a619eb49d12ddf2d613674cba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf5b65d7cd6595739887ab60a960dc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0ac5aac4b06caf7d500375316053846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cf65da26404caedcb7e190baac1bbfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a71dc1483d96ed66ad02fc4c898b71be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c56c8ea050ec677be2ef9ae227aa2d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f85c92ab988607a725d952374690a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123b8ffcaf5460cda2002f105db51a95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123e73e40f33cd0f4b9dbb3faea3fa9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edac229fc5a52272cfebb6d0773ab39e
publicationDate 1993-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PT-100855-A
titleOfInvention The use of a bicyclic heterocyclic compound, in particular a benzodioxan derivative, for the preparation of a medicament
abstract This invention relates to the use of a compound of formula I <IMAGE> or a pharmaceutically acceptable salt thereof in which X1-(CH2)x-X2 forms a 5 to 7 member ring in which X1 represents O or S, X2 represents O, S, NR or NRCO, where R represents hydrogen or alkyl containing 1 to 6 carbon atoms, x represents 1, 2 or 3, R1, R2, R3, R4 and R5 represent e.g. hydrogen or alkyl containing 1 to 6 carbon atoms, Y represents O or NH, and Z is e.g. substituted piperidyl methyl, or a compound of formula I in which the CO-Y bond is substituted by a heterocyclic bioisostere, in the preparation of a drug for use in the treatment of gastrointestinal disturbances, cardiovascular disturbances and disturbances of the central nervous system.
priorityDate 1991-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407740905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10301

Total number of triples: 28.